Intranasal Ketorolac versus Intravenous Ketorolac for Treatment of Migraine Headaches in Children: A Randomized Clinical Trial

CONCLUSIONS: Intranasal ketorolac was non-inferior to intravenous ketorolac for reducing migraine headache pain in the emergency department.PMID:34822214 | DOI:10.1111/acem.14422

Source: Accident and Emergency Nursing - November 25, 2021 Category: Emergency Medicine Authors: Daniel S Tsze Tamar R Lubell Robert C Carter Lauren S Chernick Kerrin C DePeter Son H McLaren Maria Y Kwok Cindy G Roskind Ariana E Gonzalez Weijia Fan Shannon E Babineau Benjamin W Friedman Peter S Dayan Source Type: research